Defining the Optimal Gene Therapy Approach of Human Hematopoietic Stem Cells for the Treatment of Dedicator of Cytokinesis 8 (DOCK8) Deficiency

  • Post author:
  • Post category:

Research Objective A new therapeutic option for DOCK8 deficiency using autologous human hematopoietic stem cells modified through either lentiviral gene addition or CRISPR/Cas9 based gene editing. Impact Allogeneic HSCT is…

Continue ReadingDefining the Optimal Gene Therapy Approach of Human Hematopoietic Stem Cells for the Treatment of Dedicator of Cytokinesis 8 (DOCK8) Deficiency

Modulation of oral epithelium stem cells by RSpo1 for the prevention and treatment of oral mucositis

  • Post author:
  • Post category:

Research Objective Locally delivered formulation of RSpo1 protein as an activator of Lgr5+ epithelial stem cells in chemotherapy- or radiation therapy-induced oral mucositis Impact Oral mucositis Major Proposed Activities RSpo1…

Continue ReadingModulation of oral epithelium stem cells by RSpo1 for the prevention and treatment of oral mucositis

New noncoding RNA chemical entity for heart failure with preserved ejection fraction.

  • Post author:
  • Post category:

Research Objective Modified synthetic noncoding RNA molecule Impact Heart failure with preserved ejection fraction Major Proposed Activities Lead optimizationPerform extensive preclinical testing and select a therapeutic candidate.Develop and test preliminary…

Continue ReadingNew noncoding RNA chemical entity for heart failure with preserved ejection fraction.